Mesoblast (MESO) Current Leases (2019 - 2025)
Mesoblast's (MESO) quarterly Current Leases came in at $5.9 million in Q4 2025, up 24.04% year-on-year from $4.8 million in Q4 2024, and up 64.44% quarter-over-quarter from $3.6 million in Q2 2025.
Mesoblast (MESO) Current Leases (2019 - 2025) Analysis & Trends
Mesoblast has disclosed Current Leases across 7 years of filings, most recently posting $5.9 million for Q4 2025.
- Current Leases for Q4 2025 came in at $5.9 million, up 24.04% year-over-year; the trailing twelve-month figure through Dec 2025 was $5.9 million (up 24.04% YoY), and the FY2025 annual result was $3.6 million, up 36.44% from the prior year.
- Current Leases came in at $5.9 million for Q4 2025 at Mesoblast, up from $3.6 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $8.5 million in Q2 2021 to a low of $2.6 million in Q2 2024.
- The 5-year median for Current Leases is $5.0 million (2022), against an average of $5.5 million.
- Across the five-year window, Current Leases slumped 62.45% in 2022 and jumped 40.28% in 2024, its largest moves.
- Mesoblast's Current Leases stood at $7.9 million in 2021, then slumped by 37.04% to $5.0 million in 2022, then plunged by 32.28% to $3.4 million in 2023, then soared by 40.28% to $4.8 million in 2024, then advanced by 24.04% to $5.9 million in 2025.
- The last three Current Leases figures came in at $5.9 million (Q4 2025), $3.6 million (Q2 2025), and $4.8 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Mesoblast | 21.68 Bn | 21.55 Bn | - | 5.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.89 Mn |
| Jun 30, 2025 | 3.58 Mn |
| Dec 31, 2024 | 4.75 Mn |
| Jun 30, 2024 | 2.63 Mn |
| Dec 31, 2023 | 3.39 Mn |
| Jun 30, 2023 | 4.06 Mn |
| Mar 31, 2023 | 4.65 Mn |
| Dec 31, 2022 | 5.00 Mn |
| Sep 30, 2022 | 6.35 Mn |
| Jun 30, 2022 | 3.19 Mn |
| Mar 31, 2022 | 8.05 Mn |
| Dec 31, 2021 | 7.94 Mn |
| Sep 30, 2021 | 7.56 Mn |
| Jun 30, 2021 | 8.49 Mn |
| Mar 31, 2021 | 6.48 Mn |
| Dec 31, 2020 | 6.51 Mn |
| Sep 30, 2020 | 7.05 Mn |
| Jun 30, 2020 | 6.32 Mn |
| Mar 31, 2020 | 5.76 Mn |
| Dec 31, 2019 | 6.68 Mn |